SMTL ID : 8k4q.1

Crystal structure of nanobody HuNb103 bound to human interleukin-4 receptor subunit alpha

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.59 Å

Oligo State

hetero-2-2-mer

Ligands

2 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG-NAG.1: 3 residues within 4Å: Chain A: N.73, T.75, S.89 No protein-ligand interaction detected (PLIP) NAG-NAG.3: 3 residues within 4Å: Chain A: N.151, T.153, Q.181 No protein-ligand interaction detected (PLIP)

2 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose

NAG-NAG-BMA.2: 3 residues within 4Å: Chain A: H.107, N.109, V.110 No protein-ligand interaction detected (PLIP) NAG-NAG-BMA.4: 3 residues within 4Å: Chain C: N.73, S.89, K.91 No protein-ligand interaction detected (PLIP)

4 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG.5: 3 residues within 4Å: Chain A: E.94, Y.183, N.184 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:E.94, A:N.184 Water bridges: A:N.184 NAG.6: 4 residues within 4Å: Chain C: T.133, N.151, W.179, W.187 No protein-ligand interaction detected (PLIP) NAG.7: 3 residues within 4Å: Chain C: E.94, Y.183, N.184 2 PLIP interactions: 2 interactions with chain C Water bridges: C:E.94, C:H.95 NAG.8: 5 residues within 4Å: Chain C: A.100, G.102, N.103, S.119, P.121 3 PLIP interactions: 3 interactions with chain C Hydrophobic interactions: C:P.121 Hydrogen bonds: C:N.103, C:S.119

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Zhu, M. et al., A novel inhalable nanobody targeting IL-4R alpha for the treatment of asthma. J.Allergy Clin.Immunol. (2024)

Release Date

2024-06-26

Peptides

Interleukin-4 receptor subunit alpha: AC
IL-4R nanobody HuNb103: BD

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

C
C

B
B

D
D

Interleukin-4 receptor subunit alpha

IL-4R nanobody HuNb103